Merial Limited

Merial Sas

Cerebus Biologicals Inc.

Eaton, Kathryn

George Krakowka

John Ellis

Brian Martin Meehan

Gordon Moore Allan

Jean-Christophe Francis Audonnet

Catherine Elisabeth Charreyre

John R Harding

Gilles Emile Chappuis

Edward Clark

Lori Hassard

Francis McNeilly

Deborah Haines

Jean-ChrJistophe Francis Audonnet

Joel Flores

Kathryn Eaton

Kathyrn Eaton

Kathym Eaton

Compositions and methods for treating, preventing and diagnosinginfection are disclosed. The methods use proteins and/or nucleic acids derived from, a new pathogen isolated from swine. In addition, porcine models for studying bacterial gastritis and gastric and duodenal ulcer disease caused bypathogens, such asandare described, as well as methods of identifying vaccines and compounds for treating and/or preventinginfection using the animal models. Also described are methods of preventinginfection in swine, such as infection caused by, using immunogenic proteins and nucleic acids derived frompathogens, such as

[object Object]

Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.

Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2

The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.

Porcine circovirus and parvovirus vaccine

Growing community of inventors

Colombus, OH, United States of America

George Krakowka